Portage Biotech Regains Full Compliance with Nasdaq Continued Listing Requirements

Core Points - Portage Biotech Inc. has received formal notice from The Nasdaq Stock Market LLC confirming compliance with all applicable requirements for continued listing on The Nasdaq Capital Market as of June 24, 2025 [1] - Portage Biotech is a clinical-stage immuno-oncology company focused on advancing a pipeline of novel biologics aimed at enhancing the immune system's ability to combat cancer [2]